Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mHSPC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06177015
What this trial is testing

Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC

Who this might be right for
Metastatic Prostate CancerIntermitent Anti-androgen Therapy
The First Affiliated Hospital with Nanjing Medical University 200
Early research (Phase 1)Not Yet RecruitingNCT06099990
What this trial is testing

Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

Who this might be right for
High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
Jiangsu HengRui Medicine Co., Ltd. 660
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07795177
What this trial is testing

A Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer.

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Anhui Medical University 40
Not applicableStudy completedNCT06151418
What this trial is testing

Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

Who this might be right for
Prostatic Neoplasms
Pfizer 2,313
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649421
What this trial is testing

PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
West China Hospital 254
Testing effectiveness (Phase 2)Active Not RecruitingNCT03951831
What this trial is testing

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Mark Stein 26
Large-scale testing (Phase 3)Active Not RecruitingNCT05676203
What this trial is testing

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Jena University Hospital 250
Not applicableActive Not RecruitingNCT06874114
What this trial is testing

An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer
Bayer 700
Post-approval studies (Phase 4)Active Not RecruitingNCT06479187
What this trial is testing

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate CancerHormone Sensitive Prostate CancerMetastatic Hormone-sensitive Prostate Cancer (mHSPC)
Brigham and Women's Hospital 20
Not applicableUnknownNCT05530395
What this trial is testing

BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC

Who this might be right for
Prostate Cancer Metastatic
Ignacio Puche Sanz 300
Very early researchNot Yet RecruitingNCT07389174
What this trial is testing

Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
mHSPCmHNPCProstate Cancer Adenocarcinoma
Shanghai Changzheng Hospital 40
Not applicableLooking for participantsNCT06835218
What this trial is testing

PROCARE - PROstate Cancer Real World Evidence Registry

Who this might be right for
Prostate CancerBiochemical Recurrence of Malignant Neoplasm of ProstateNon-metastatic Castration-resistant Prostate Cancer+2 more
UroTrials Company (GmbH) 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05717582
What this trial is testing

Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

Who this might be right for
Metastatic Prostate CancerCastration-Sensitive Prostate Cancer
Fudan University 47
Not applicableLooking for participantsNCT07089550
What this trial is testing

PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)

Who this might be right for
PSMA Positive Tumors or Tumor TissuesProstate Cancer Metastatic
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04925063
What this trial is testing

The Effect of Metformin in Patients With Newly Diagnosed mHSPC

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 266